Association of Continued Use of SGLT2 Inhibitors From the Ambulatory to Inpatient Setting With Hospital Outcomes in Patients With Diabetes: A Nationwide Cohort Study.
Lakshmi G SinghSpyridon NtelisTariq SiddiquiStephen L SeligerJohn D SorkinElias K SpanakisPublished in: Diabetes care (2023)
Continued SGLT2i during hospitalization among patients with diabetes was associated with lower mortality, no increased AKI, and shorter LOS.